Prognostic relevance of risk groups in the pediatric AML-BFM trials 93 and 98.
Creutzig
U
U
University Children's Hospital, Department of Hematology/Oncology, Münster, Germany.
Reinhardt
D
D
Zimmermann
M
M
D000208:Acute Disease; D002648:Child; D002675:Child, Preschool; D018572:Disease-Free Survival; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007223:Infant; D007621:Karyotyping; D007951:Leukemia, Myeloid / Q000145:classification / Q000235:genetics / Q000401:mortality / Q000628:therapy*; D008297:Male; D015996:Survival Rate; D013997:Time Factors